The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Fesoterodine Doc 4 mg prolonged-release tablets

DOC Generici S.r.l.PA2244/002/001

Main Information

Trade NameFesoterodine Doc 4 mg prolonged-release tablets
Active SubstancesFesoterodine fumarate
Dosage FormProlonged-release tablet
Licence HolderDOC Generici S.r.l.
Licence NumberPA2244/002/001

Group Information

ATC CodeG04BD11 fesoterodine


License statusAuthorised
Licence Issued12/08/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0139-008-024
Interchangeable List DocumentPDF of Interchangeable List
« Back